首页 > 市场调查报告书 > 製药

开发平台分析

市场调查报告书

商品编码

1741208

巨噬细胞标记物市场按标记物类型、应用、疾病领域、最终用户和地区划分

Macrophage Marker Market, By Marker Type, By Application, By Disease Area, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

巨噬细胞标记市场规模预计在 2025 年为 2.903 亿美元，预计到 2032 年将达到 4.511 亿美元，2025 年至 2032 年的复合年增长率为 6.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	2.903亿美元
效能数据	2020-2024	预测期	2025-2032
预测期间：2025年至2032年的复合年增长率	6.50%	2032年价值预测	4.511亿美元

巨噬细胞是在免疫和体内平衡中发挥关键作用的白血球。它们是吞噬异物、微生物和碎片的第一个反应者。由于其重要性，表征和研究巨噬细胞的生物学至关重要。巨噬细胞标记使研究人员能够识别、分离、追踪和标靶化这些细胞。巨噬细胞标记主要有两种类型。第一种类型是细胞表面标誌物标记物，它们是在巨噬细胞外膜上表现的蛋白质，可以使用萤光活化细胞分选或免疫组织化学检测。常见的巨噬细胞表面标誌物包括 CD68、CD14、CD163 和 CD206。第二种是细胞内标记物，它们是存在于巨噬细胞内部的蛋白质。

细胞内标记提供有关巨噬细胞活化和功能的信息，但需要细胞固定和透化。细胞表面标誌物的优点在于可以进行活细胞分析、分离和标靶化巨噬细胞。然而，没有一种标记物特异性足够强，能够唯一地识别巨噬细胞，且标记物的表达会因活化状态和组织环境而异。为了准确表征巨噬细胞表型和细胞群，多种标记的组合是理想的选择。全球市场提供各种针对巨噬细胞标记的单株抗体，有助于基础研究和应用研究，从而寻找跨疾病状态的新治疗策略。

市场动态

免疫学研究的兴起、慢性病盛行率的增加、技术进步和个人化医疗方法是预计在预测期内推动全球巨噬细胞标记市场成长的关键因素。
例如，印度国家生物技术资讯中心 2022 年 6 月发布的一份报告称，印度约 21% 的老年人患有至少一种慢性疾病。
同时，根据国际抗癌联盟2020年12月发布的报告，全球整体每五人中就有一人会在一生中罹患癌症，每八名男性中就有一人、每十一名女性中就有一人会死于癌症。
然而，巨噬细胞异质性的复杂性、缺乏特异性和敏感性以及有效抗体的有限性预计将在预测期内阻碍全球巨噬细胞标记市场的成长。

研究的主要特点

本报告对全球巨噬细胞标记市场进行了详细分析，并以 2024 年为基准年，给出了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数，介绍了全球巨噬细胞标誌物市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球巨噬细胞标誌物市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过全球巨噬细胞标记市场分析中使用的各种策略矩阵来做出决策。

介绍
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- 东南亚国协
- 其他亚太地区
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
非洲
- 南非
- 北非
- 中部非洲

第十章竞争格局

Abcam plc
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
BD Biosciences
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
BioLegend, Inc.
Merck KGaA
Novus Biologicals, LLC
R&D Systems, Inc.（Bio-Techne品牌）
Santa Cruz BIoTechnology, Inc.
Beckman Coulter, Inc.
Miltenyi BIoTec GmbH
GeneTex, Inc.
MBL International Corporation

第 11 章章节

调查方法
关于出版商

简介目录

Product Code: CMI5945

Macrophage Marker Market is estimated to be valued at USD 290.3 Mn in 2025 and is expected to reach USD 451.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 290.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 451.1 Mn

Macrophages are white blood cells that play a key role in immunity and homeostasis. They act as first responders, ingesting foreign materials, microbes, and debris. Due to their importance, it is essential to characterize and study macrophage biology. Macrophage markers allow researchers to identify, isolate, track, and target these cells. There are two main types of macrophage markers. The first are cell surface markers, which are proteins expressed on the outer membrane of macrophages that can be detected using fluorescence-activated cell sorting or immunohistochemistry techniques. Common macrophage cell surface markers include CD68, CD14, CD163, and CD206. The second type are intracellular markers, which are proteins located inside macrophage cells.

Intracellular markers provide information about macrophage activation and function but require fixed and permeabilized cells. Cell surface markers have the advantage of allowing live cell analysis, isolation, and potentially targeting of macrophages. However, no single marker is specific enough to uniquely identify macrophages, and marker expression can change depending on activation state and tissue environment. Ideally, a combination of several markers is used to accurately characterize macrophage phenotypes and populations. The global market offers a wide variety of monoclonal antibodies against macrophage markers, aiding fundamental and applied research seeking new treatment strategies across medical conditions.

Market Dynamics

Increasing research in immunology, the growing prevalence of chronic diseases, technological advancements, and personalized medicine approaches are major factors expected to drive growth of the global macrophage marker market during the forecast period.
For instance, in June 2022, according to a report published by the National Center for Biotechnology information, approximately 21% of the elderly in India reportedly have at least one chronic disease.
While, in December 2020, according to a report published by the Union for International Cancer Control, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.
However, the complexity of macrophage heterogeneity, a lack of specificity and sensitivity, and the limited availability of validated antibodies are expected to hamper growth of the global macrophage marker market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global macrophage marker market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global macrophage marker market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global macrophage marker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global macrophage marker market

Macrophage Marker Market Detailed Segmentation:

By Marker Type:
- CD68
- CD163
- CD206
- CD14
- CD11b
- CD64
- CD11c
- Others
By Application:
- Research Use
- Diagnostic Use
- Drug Development
By Disease Area:
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End User:
- Research Institutes and Academic Centers
- Pharmaceutical and Biotechnology Companies
- Clinical and Diagnostic Laboratories
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Abcam plc
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- BD Biosciences
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- BioLegend, Inc.
- Merck KGaA
- Novus Biologicals, LLC
- R&D Systems, Inc. (a Bio-Techne brand)
- Santa Cruz Biotechnology, Inc.
- Beckman Coulter, Inc.
- Miltenyi Biotec GmbH
- GeneTex, Inc.
- MBL International Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Macrophage Marker, By Marker Type
- Market Macrophage Marker, By Application
- Market Macrophage Marker, By Disease Area
- Market Macrophage Marker, By End User
- Market Macrophage Marker, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Macrophage Marker Market, By Marker Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
CD68
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD163
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD206
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD14
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD11b
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD64
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD11c
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Macrophage Marker Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Research Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Diagnostic Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Drug Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Macrophage Marker Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Research Institutes and Academic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Macrophage Marker Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2028
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abcam plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cell Signaling Technology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BD Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioLegend, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novus Biologicals, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
R&D Systems, Inc. (a Bio-Techne brand)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Santa Cruz Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Miltenyi Biotec GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GeneTex, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MBL International Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

巨噬细胞标记物市场按标记物类型、应用、疾病领域、最终用户和地区划分

Macrophage Marker Market, By Marker Type, By Application, By Disease Area, By End User, By Geography

市场动态

研究的主要特点

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

第四章全球巨噬细胞标记市场-冠状病毒（COVID-19）大流行的影响

5. 全球巨噬细胞标记市场（依标记类型），2020 年至 2032 年

6. 全球巨噬细胞标记市场（按应用），2020 年至 2032 年

7. 2020 年至 2032 年按疾病领域分類的全球巨噬细胞标记市场

8. 全球巨噬细胞标记市场（依最终用户划分），2020 年至 2032 年

9. 全球巨噬细胞标记市场（按地区），2020 年至 2032 年

第十章竞争格局

第 11 章章节

Market Dynamics

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Macrophage Marker Market, By Marker Type, 2020-2032, (US$ Mn)

6. Global Macrophage Marker Market, By Application, 2020-2032, (US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2020-2032, (US$ Mn)

8. Global Macrophage Marker Market, By End User, 2020-2032, (US$ Mn)

9. Global Macrophage Marker Market, By Region, 2020-2032, (US$ Mn)

10. Competitive Landscape

11. Section

巨噬细胞标记物市场按标记物类型、应用、疾病领域、最终用户和地区划分

Macrophage Marker Market, By Marker Type, By Application, By Disease Area, By End User, By Geography

市场动态

研究的主要特点

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

第四章 全球巨噬细胞标记市场-冠状病毒（COVID-19）大流行的影响

5. 全球巨噬细胞标记市场（依标记类型），2020 年至 2032 年

6. 全球巨噬细胞标记市场（按应用），2020 年至 2032 年

7. 2020 年至 2032 年按疾病领域分類的全球巨噬细胞标记市场

8. 全球巨噬细胞标记市场（依最终用户划分），2020 年至 2032 年

9. 全球巨噬细胞标记市场（按地区），2020 年至 2032 年

第十章 竞争格局

第 11 章 章节

Market Dynamics

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Macrophage Marker Market, By Marker Type, 2020-2032, (US$ Mn)

6. Global Macrophage Marker Market, By Application, 2020-2032, (US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2020-2032, (US$ Mn)

8. Global Macrophage Marker Market, By End User, 2020-2032, (US$ Mn)

9. Global Macrophage Marker Market, By Region, 2020-2032, (US$ Mn)

10. Competitive Landscape

11. Section

第一章调查目的与前提条件

第二章市场展望

第四章全球巨噬细胞标记市场-冠状病毒（COVID-19）大流行的影响

第十章竞争格局

第 11 章章节